cell and gene therapies

InspiroGene by McKesson Unveils ‘First-of-its-Kind’ Report on State of the Cell and Gene Therapy Landscape

by | Oct 15, 2024
Newly launched InspiroGene conducted a survey of 124 oncologists to better understand the current use of cell and gene therapies—and possible barriers to future adoption. The report proposes possible solutions to broaden access for more patients.
MORE
North Texas’ McKesson Launches InspiroGene to Support Commercialization of Cell and Gene Therapies
by | Oct 1, 2024
McKesson said that with a scalable, flexible suite of services and an experienced leadership team, InspiroGene enables manufacturers, payers, and providers to navigate the complex CGT commercialization landscape—ensuring that "patients can access the life-changing treatments they need."
MORE